A detailed history of Watershed Asset Management, L.L.C. transactions in Repligen Corp stock. As of the latest transaction made, Watershed Asset Management, L.L.C. holds 8,900 shares of RGEN stock, worth $1.41 Million. This represents 1.87% of its overall portfolio holdings.

Number of Shares
8,900
Previous 7,000 27.14%
Holding current value
$1.41 Million
Previous $1.11 Million 43.76%
% of portfolio
1.87%
Previous 1.34%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 02, 2024

BUY
$114.17 - $185.35 $216,923 - $352,165
1,900 Added 27.14%
8,900 $1.6 Million
Q2 2023

Jul 28, 2023

BUY
$138.42 - $180.31 $968,939 - $1.26 Million
7,000 New
7,000 $990,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.78B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Watershed Asset Management, L.L.C. Portfolio

Follow Watershed Asset Management, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Watershed Asset Management, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Watershed Asset Management, L.L.C. with notifications on news.